Skip to content
AnalystLens
Back to TEVAIncome Statement

Teva Pharmaceutical Industries Revenue 2007-2026 | TEVA

Annual FY2007–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$17.26B

+4.3%YoY vs FY2024Source: 10-KFY2025

From $9.41B in FY2007 to $17.26B in FY2025: 1.8× in 18 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$4.0B+2.3%$4.1B−0.8%$4.4B−1.9%Not reported
FY25$3.9B+1.9%$4.2B+0.3%$4.5B+3.4%$1.5B−64.5%
FY24$3.8B+4.3%$4.2B+7.4%$4.3B+12.5%$4.2B−5.1%
FY23$3.7B0.0%$3.9B+2.4%$3.9B+7.1%$4.5B+14.8%
FY22$3.7B−8.1%$3.8B−3.2%$3.6B−7.5%$3.9B−5.3%
Share25%25%26%24%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+0.7%

FY2020
$16.66B
FY2025
$17.26B

5 years selected · on the chart

01—History

Revenue History

Year-over-year comparison from 10-K annual reports

  19. $17.26B
YoY changeLargest recent move−18.4%in FY18Latest +4.3%

1 older move runs past ±20% (largest +45.4%); point at, tap or drag across the bars to read one.

02—Ledger

Revenue, period by period

PeriodValueChangeSource
FY2025$17.26B+4.3%10-K
FY2024$16.54B+4.4%10-K
FY2023$15.85B+6.2%10-K
FY2022$14.93B−6.0%10-K
FY2021$15.88B−4.7%10-K
FY2020$16.66B−1.4%10-K
FY2019$16.89B−7.6%10-K
FY2018$18.27B−18.4%10-K
FY2017$22.39B+2.2%10-K
FY2016$21.90B+11.5%10-K
FY2015$19.65B−3.1%10-K
FY2014$20.27B−0.2%10-K
FY2013$20.31B0.0%flat10-K
FY2012$20.32B+10.9%10-K
FY2011$18.31B+13.6%10-K
FY2010$16.12B0.0%flat10-K
FY2009$16.12B+45.4%10-K
FY2008$11.09B+17.8%10-K
FY2007$9.41B—10-K

03—Questions

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Teva Pharmaceutical Industries's current revenue?

Teva Pharmaceutical Industries (TEVA) annual revenue for 2025 was $17.26B, a 4.32% increase from 2024. Teva Pharmaceutical Industries revenue for the quarter ending September 30, 2026 was $4.39B.

What was Teva Pharmaceutical Industries's revenue in 2024?

Teva Pharmaceutical Industries annual revenue for 2024 was $16.54B, a 4.40% increase from 2023.

What was Teva Pharmaceutical Industries's revenue in 2023?

Teva Pharmaceutical Industries annual revenue for 2023 was $15.85B, a 6.17% increase from 2022.

What is Teva Pharmaceutical Industries's 5-year revenue CAGR?

Teva Pharmaceutical Industries revenue grew at a compound annual growth rate (CAGR) of 0.71% from FY2020 to FY2025, going from $16.66B to $17.26B over 5 years.

Company
Teva Pharmaceutical Industries
Ticker
TEVA
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →